The American Association for Homeopathic Products

AAHP 2024 Annual Membership Meeting
2024-03-08 12:00 - 14:00 (America/New_York)
AAHP Annual Membership Meeting

Exclusive to AAHP Members is this annual briefing on the latest legal and regulatory issues from AAHP Legal Counselor Al Lorman, Esq. and on federal programs affecting your business from AAHP Lobbyist Pete Evich of Van Scoyoc Associates. Emerging issues and critical topics will be addresssed as necessary. Additionally, AAHP officers will provide updates on association projects.
Event Information

Virtual Only
Friday, March 8, 2024 from 12:00pm-2:00pm EDT
Complimentary to AAHP Members, but registration is required
Closed to non-members

Please do not de-value your membership by sharing the link with non-members.
Who Should Attend at AAHP Member Companies

Government Affairs Team
Compliance Officers and Quality Assurance Team
Lab and Production Managers
Marketing Team
R&D Team
Company Executives, including CEOs

Questions from members are welcomed prior or during the event. Please contact AAHP Secretary Eric Foxman at email at Info@AAHP.Info or by voice message at 513-402-8847.

Water Treatment Systems Seminar
2024-06-12 12:00 - 16:00
AAHP Water Treatment Systems Seminar

The American Association of Homeopathic Pharmacists is excited to present a virtual seminar on Water Treatment Systems for our industry. This event is open to both AAHP members and non-members.
3 Crucial Topics Discussed in Depth
A half-day cGMP seminar focused on one of the most common reasons for an FDA warning letter regarding homeopathic products: microbial contamination in non-sterile drug products. The webinar will facilitate a better understanding of water treatment system design and compliance requirements. It will help you improve product quality and be well prepared for FDA inspections.
William Yang, Ph.D., Consumer Safety Officer, FDA CDER
Discussion on trends in CGMP deviations and violations pertaining to pharmaceutical water purification systems noted in recent FDA drug warning letters.
Christine Craig, Ph.D., Microbiology Consultant, ValSource, Inc.
Discussion on microbiological control of water treatment systems.
Josh Capsavage, Senior Business Development Manager, Xylem
Practical overview and engineering perspective on designing water treatment systems.
Understanding water treatment systems design and what FDA takes into consideration is essential for all ongoing cGMP compliance efforts for all products produced using water. Mastering these focus areas will also better prepare your company for inspections and minimize potential impact on your day-to-day business activities. Ultimately this crucial education leads to manufacturing excellence and the production of safe, high quality, and pharmaceutical-grade homeopathic products. It also helps your company meet its compliance with statutory requirements for ongoing employee education.

Tickets

Agenda

Event Information
Virtual Only
Wednesday, June 12, 2024
from 12:00 p.m. (9 a.m. PDT) – 4:00 p.m. EDT (1 p.m. PDT)
Open to non-members; AAHP members receive a discount.
What You Will Learn

Overview and examples of inspection enforcement.
GMP requirements for water treatment systems.
Design of an effective water treatment system.
Microbiological quality standards for pharmaceutical water systems.
FDA hot topics.

Who Should Attend
This seminar is a must-attend for all domestic and foreign firms who manufacture, label, pack, or hold homeopathic drug products for sale in the United States. Individuals who will find it worthwhile include:

Quality Staff
Legal & Regulatory Staff
Product Leads
Product R&D Staff
Company Leaders (President/CEO)
And those similarly responsible at your contract manufacturer

Please contact AAHP Secretary Eric L. Foxman via email at Info@AAHP.Info or by voice message at 513-402-8847 with questions.

Tickets

Agenda
All times below are in Eastern Daylight Time.

12:00-12:10pm
Mark Land, M.S., RAC, AAHP – Welcome

12:10-1:10pm
Christine Craig, Ph.D., Valsource, Inc. – Microbiological Control of Water Treatment Systems

1:10-1:25pm
Break

1:25-2:25pm
Josh Capsavage, Xylem Water Technologies – Water Treatment System Design

2:25-2:40pm
Break

2:40-3:40pm
William Yang, Ph.D., FDA – Recent CGMP Deficiency Trends in Pharmaceutical Water Purification Systems

3:40-3:50pm
Mark Land, M.S., RAC, AAHP – Closing

About the Speakers
Christine Craig, Ph.D.

Microbiological Control of Water Treatment SystemsPresented by Christine Craig, Ph.D.Microbiology Consultant, ValSource, Inc.
Dr. Christine Craig is a microbiology consultant with ValSource, Inc. She has more than 15 years’ experience as a microbiologist with extensive expertise in pathogens and contamination control strategies. She has 6 years of specialized FDA regulatory experience performing risk-based product quality assessments of sterile and non-sterile drug products and has served as a microbiology subject matter expert (SME) within the Agency for contamination events, inspections, and 483 responses. As a microbiology consultant at ValSource, Inc., she applies her scientific and regulatory experiences to help ensure microbiological quality and safety in the pharmaceutical manufacturing industry. Dr. Craig’s goal and passion is to help industry meet or exceed FDA regulatory compliance requirements, while maintaining practical manufacturing processes. She holds a B.S in medical microbiology from University of California, Davis and a Ph.D. in molecular microbiology and immunology from Johns Hopkins University School of Public Health.
Josh Capsavage

Water Treatment System DesignPresentation by Josh CapsavageSenior Business Development Manager, Xylem
Josh Capsavage is a seasoned expert in water filtration, boasting a rich background encompassing quality control, process validation, and the engineering and design of water filtration systems tailored for both pharmaceutical and homeopathic sectors. With more than 18 years of extensive experience in sales and cGMP practices, he specializes in turn-key engineering, installation, and qualification of pure water systems. Recently appointed as the Senior Business Development Manager at Xylem Water, Josh directs his attention towards capital equipment and installation projects. Proudly based in Southern California, he resides with his wife Rachel and their three daughters, Ava, Emma, and Olivia.
William Yang, Ph.D.
Recent CGMP Deficiency Trends in Pharmaceutical Water Purification SystemsPresented by William Yang, Ph.D.Consumer Safety Officer, FDA
William Yang, Ph.D. is a consumer safety officer in the Office of Manufacturing Quality, Office of Compliance within the Center for Drug Evaluation and Research at FDA. He has been with FDA since 2016. Prior to FDA, he was a senior process development engineer at a biotechnology company.
Special Q&A with Two FDA Officials
Special Q&A with Two FDA Officials
A second FDA representative will join Dr. Yang for a special Q&A after his presentation. Tamara L. Ely, Branch Chief in the FDA’s Office of Manufacturing Quality, Office of Compliance within CDER has previously addressed the homeopathic industry at the AAHP GMP Compliance Seminar, October 2023.

Register

Early bird pricing is available through May 20, 2024 at 11:59pm EDT.

AAHP Semiannual Membership Meeting
2024-09-27 11:00 - 12:30
AAHP Semiannual Membership Meeting

Exclusive to AAHP Members is this semiannual briefing on the latest legal and regulatory issues from AAHP Legal Counselor Al Lorman, Esq. and on federal programs affecting your business from AAHP Lobbyist Pete Evich of Van Scoyoc Associates. Emerging issues and critical topics will be addresssed as necessary. Additionally, AAHP officers will provide updates on association projects.

Registration Now Open

Event Information

Virtual Only
Friday, September 27, 2024 from 11:00am-12:30pm EDT
Complimentary to AAHP Members, but registration is required
Closed to non-members

Please do not de-value your membership by sharing the link with non-members.
Meet our Guest Speaker: Jingjing Qian, PhD, Associate Professor, Harrison College of Pharmacy, Auburn University, Auburn, Alabama

Through the American Foundation for Pharmaceutical Education (AFPE), Dr. Qian will be working on a study proposed by AAHP on the safety of homeopathic drug products. The year-long study will examine adverse events and their characteristics in the FDA FAERS data, as well as quantitatively assess reporting risk of serious AEs associated with homeopathic drugs. Findings of this project will provide an up to date and fundamental safety profile of marketed homeopathic drugs, which further supports a well-informed legislative and regulatory environment for homeopathic products in the United States.
Also joining us will be AFPE president Ellen Woods who spoke at AAHP’s October 2023 membership meeting.

Who Should Attend at AAHP Member Companies

Government Affairs Team
Compliance Officers and Quality Assurance Team
Lab and Production Managers
Marketing Team
R&D Team
Company Executives, including CEOs

Agenda:

Welcome by Mark Land.
Study on the safety of homeopathic drug products by Jingjing Qian, PhD.
Legal and regulatory update from Al Lorman.
A look at how incoming administrations have in the past and may in the future affect our industry by Pete Evich.
New resource on history and future of homeopathy by Alissa Gould.
Q&A during each section.
Closing.

Questions from members are welcomed prior or during the event. Please contact AAHP Secretary Eric Foxman at email at Info@AAHP.Info or by voice message at 513-402-8847.

Registration Now Open

AAHP 2025 Annual Membership Meeting
2025-03-21 12:00 - 14:00
AAHP Annual Membership Meeting
Exclusive to AAHP Members is this annual briefing on the latest legal, regulatory, and federal issues affecting your business. Hear the impact of transitions from Washington insider and AAHP Lobbyist Pete Evich of Van Scoyoc Associates. Get updates on Alliance for Natural Health’s lawsuit against FDA from AAHP Legal Counselor Al Lorman. Participate in elections for AAHP’s Board of Directors and learn about AAHP’s future working structure as longtime AAHP Secretary Eric Foxman prepares for retirement.
RSVP Required
Event Information

Virtual Only
Friday, March 21, 2025 from 12:00pm-2:00pm EDT
Complimentary to AAHP Members, but registration is required
Closed to non-members

Please do not de-value your membership by sharing the link with non-members.
Who Should Attend at AAHP Member Companies

Government Affairs Team
Compliance Officers and Quality Assurance Team
Lab and Production Managers
Marketing Team
R&D Team
Company Executives, including CEOs

RSVP Required
Questions from members are welcomed prior or during the event. Please contact AAHP Secretary Eric Foxman at email at Info@AAHP.Info or by voice message at 513-402-8847.

2025 AAHP Semiannual Membership Meeting
2025-10-17 11:00 - 13:00 | Virtual
AAHP Semiannual Membership Meeting

Exclusive to AAHP Members is this semiannual briefing on the latest legal and regulatory issues from AAHP Legal Counselor Al Lorman, Esq. and on federal programs affecting your business from AAHP Lobbyist Pete Evich of Van Scoyoc Associates. Emerging issues and critical topics will be addressed. Additionally, AAHP officers will provide updates on association projects.

Registration Now Open

Event Information

Virtual via Zoom
Friday, October 17, 2025 from 11:00am-1:00pm EDT
Complimentary for AAHP Members (registration required)
Closed to non-members

Please do not de-value your membership by sharing the meeting link with non-members.
Who Should Attend at AAHP Member Companies

Government Affairs Team
Compliance Officers and Quality Assurance Team
Lab and Production Managers
Marketing Team
R&D Team
Company Executives, including CEOs

Agenda:
coming soon!
Please contact AAHP Secretary Eric L. Foxman via email at Info@AAHP.Info or by voice message at 513-402-8847 with questions or concerns.

Registration Now Open

AAHP 2026 Annual Membership Meeting (and Tribute to Eric Foxman)
2026-03-13 11:00 - 13:00
AAHP Annual Membership Meeting (and Tribute to Eric Foxman)
This two-part event starts with a business briefing exclusively for AAHP members. The second part is open to all in the homeopathic community as we honor Eric Foxman as he retires from AAHP.

Registration Now Open

Event Information

Virtual via Zoom
Friday, March 13, 2026
Complimentary
Registration required to receive your individual link

Who Should Attend at AAHP Member Companies

Government Affairs Team
Compliance Officers and Quality Assurance Team
Lab and Production Managers
Marketing Team
R&D Team
Company Executives, including CEOs

Agenda

President’s Welcome and Overview
Mark Land, AAHP President

AAHP Board Elections
Represent your member company in the open seats!

Legal Update
Al Lorman

ANSI Considerations for Homeopathic Products
Robert Melo, President of OHM Pharma and AAHP Board Member

Impactful Transitions
Pete Evich, Van Scoyoc Associates

Tribute to Secretary Eric Foxman
Honoring his retirement after 45 years of service to the homeopathic community

Please contact Association Manager Hayley Sotolotto via email at info@theaahp.org or by voice message at (413) 515-8133 with questions or concerns.

FDA Insights on GMP Violations & AAHP Homeopathic 483 Study Webinar
2026-06-10 12:00 - 13:30
FDA Insights on GMP Violations & AAHP Homeopathic 483 Study Webinar
Hear directly from FDA at AAHP’s upcoming webinar. Learn from the agency about compliance trends and inspection insights relevant to homeopathic drug manufacturers through AAHP’s ongoing Compliance Through Education program.
About the Program
GMP compliance-related issues remain the leading cause of FDA warning letters across the homeopathic industry. This webinar brings together regulatory perspective and industry expertise to help manufacturers better understand what FDA is looking for during inspections.
Attendees will gain practical insight into recent compliance actions, as well as a deeper understanding of common compliance gaps observed during facility inspections so companies can better prepare for their next inspection.
Event Information

Virtual via Zoom
Wednesday, June 10, 2026
12:00 PM – 1:30 ET
Complimentary to members and non-members

Registration Now Open

Featured Speakers

Francis Godwin, MBA
Director, Office of Manufacturing Quality (OMQ), Office of Compliance, CDER, FDA Francis Godwin will provide an FDA perspective on recentcompliance actions affecting homeopathic drug products, drawing on his extensive experience overseeing domestic and international CGMP compliance activities.

Eric L. Foxman, RPh (Ret.)
Senior Scientist, HPUS; Former AAHP Secretary and Board Member
With more than four decades of experience in the homeopathic industry, Eric Foxman will present a retrospective review of FDA 483 observations of inspections of homeopathic manufacturing sites, highlighting key trends and lessons to be learned.
What You Will Learn

Overview and examples of inspection compliance.

FDA’s hot topics which result in warning letters.

What inspection observations are made most often across the board.

What initial areas companies can focus on, which will make a positive difference in the 483 list of observations.

An overview of the breadth of observations for a second pass at increasing compliance before the next inspection occurs.

Who Should Attend
This seminar is a must-attend for domestic and foreign firms who manufacture, label, pack, or hold homeopathic drug products for sale in the United States.

Quality Staff

Legal & Regulatory Staff

Product Leads

Product R&D Staff

Company Leaders (President/CEO)

And those similarly responsible at your contract manufacturer

Please contact Association Manager Hayley Sotolotto via email at info@theaahp.org or by voice message at (413) 515-8133 with questions or concerns.
